Meptazinol and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Meptazinol
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Buprenorphine and meptazinol can work against each other. Both are opioids, but buprenorphine hangs onto the body's opioid receptors very tightly and only partly turns them on. Meptazinol also acts on those receptors in a mixed way. Taken together, buprenorphine can block some of meptazinol's pain relief, and this tug-of-war can even trigger withdrawal-like symptoms such as sweating, nausea, chills, or feeling agitated.
There is also a risk that both drugs pile up as sedatives, leading to heavy drowsiness, slowed breathing, or in rare cases something called serotonin syndrome. The good news is that your care team can manage this by choosing a better plan for you. Please don't stop either medicine on your own, just talk with your pharmacist or doctor.
Direction: Buprenorphine is a high-affinity partial mu-opioid agonist. Combined with meptazinol (a mixed agonist/antagonist-type opioid), buprenorphine can competitively displace/block meptazinol at the mu receptor, reducing analgesia and potentially precipitating withdrawal. Neither is a prodrug requiring activation here.
- Additive risk: CNS and respiratory depression, plus possible serotonin syndrome from additive serotonergic effects.
- Evidence: theoretical; severity: major; onset unspecified.
- Management: Avoid concomitant use where possible. If unavoidable, monitor for sedation, respiratory depression, and serotonin toxicity; use lowest effective doses, consider higher level of care, and strongly consider prescribing naloxone.
What happens
Reduced analgesic effect or precipitation of withdrawal symptoms, and an increased risk of serotonin syndrome and respiratory depression
Interaction Deep Dive
The combined use of buprenorphine with a mixed opioid agonist/antagonist or a partial agonist opioid analgesic should be avoided, since this can diminish buprenorphine's analgesic action and may trigger withdrawal symptoms. Furthermore, giving buprenorphine together with a CNS depressant can produce additive CNS depression along with a heightened risk of serotonin syndrome and respiratory depression, profound sedation, coma, and death. Discontinuing other CNS depressants is preferable to using them concurrently. In certain situations, it may be suitable to monitor in a higher level of care or to taper. In other situations, it may be suitable to gradually taper a patient off a prescribed benzodiazepine or other CNS depressant, or to reduce to the lowest effective dose. When concomitant use cannot be avoided, watch for sedation, respiratory depression, and signs and symptoms of serotonin syndrome; consider alternative options for managing anxiety or insomnia, and strongly consider prescribing naloxone for the emergency treatment of opioid overdose1.
Why it happens (mechanism)
Opioid receptor antagonism; additive serotonergic effects and respiratory depression
How to manage this interaction
What your care team may do:
- Prefer avoiding these two opioids together, since combining them can cut pain relief and cause withdrawal.
- If both are truly needed, they may watch you more closely for heavy sedation, slowed breathing, or serotonin syndrome (agitation, fast heart rate, shivering, muscle twitching).
- Doses may be adjusted and individualized, often to the lowest effective dose.
- They may prescribe naloxone for emergency use.
What you should do: Keep taking both exactly as prescribed unless told otherwise, and ask your pharmacist or prescriber before making any change. Get emergency help for very slow breathing or extreme drowsiness.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Meptazinol and Buprenorphine together?
Buprenorphine can block meptazinol's pain relief and even trigger withdrawal, while together they raise the risk of dangerous sedation and slowed breathing. Don't combine them without your care team's guidance, and never stop either on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Meptazinol and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Meptazinol and Buprenorphine interaction managed?
What your care team may do: Prefer avoiding these two opioids together, since combining them can cut pain relief and cause withdrawal. If both are truly needed, they may watch you more closely for heavy sedation, slowed breathing, or serotonin syndrome (agitation, fast heart rate, shivering, muscle twitching). Doses may be adjusted and individualized, often to the lowest effective dose. They may p… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Meptazinol or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: SUBUTEX(R) sublingual tablets, buprenorphine sublingual tablets. Indivior Inc (per FDA), North Chesterfield, VA, 2021. DailyMed
Keep reading about Buprenorphine
Keep reading about Meptazinol
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist